CN1023229C - 含有氧化-敏感性化合物的稳定性混合物,其制备及其组合物的应用 - Google Patents
含有氧化-敏感性化合物的稳定性混合物,其制备及其组合物的应用 Download PDFInfo
- Publication number
- CN1023229C CN1023229C CN89100550A CN89100550A CN1023229C CN 1023229 C CN1023229 C CN 1023229C CN 89100550 A CN89100550 A CN 89100550A CN 89100550 A CN89100550 A CN 89100550A CN 1023229 C CN1023229 C CN 1023229C
- Authority
- CN
- China
- Prior art keywords
- oxidation
- acid
- soya
- add
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 150000001875 compounds Chemical class 0.000 title claims abstract description 37
- 230000003647 oxidation Effects 0.000 title claims abstract description 35
- 238000007254 oxidation reaction Methods 0.000 title claims abstract description 35
- 239000008139 complexing agent Substances 0.000 claims abstract description 35
- 239000002253 acid Substances 0.000 claims description 37
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 28
- 239000000463 material Substances 0.000 claims description 23
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 17
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 17
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 17
- 235000019155 vitamin A Nutrition 0.000 claims description 17
- 239000011719 vitamin A Substances 0.000 claims description 17
- 229940045997 vitamin a Drugs 0.000 claims description 17
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- 229940088594 vitamin Drugs 0.000 claims description 9
- 229930003231 vitamin Natural products 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 9
- 235000021466 carotenoid Nutrition 0.000 claims description 8
- 150000001747 carotenoids Chemical class 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000003352 sequestering agent Substances 0.000 claims description 6
- 235000013311 vegetables Nutrition 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 229910001385 heavy metal Inorganic materials 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 claims description 2
- 239000000126 substance Substances 0.000 abstract description 8
- 150000003626 triacylglycerols Chemical class 0.000 abstract description 3
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 79
- 235000019198 oils Nutrition 0.000 description 79
- 235000010469 Glycine max Nutrition 0.000 description 60
- 244000068988 Glycine max Species 0.000 description 60
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 32
- 239000000843 powder Substances 0.000 description 29
- 239000006185 dispersion Substances 0.000 description 14
- 235000005979 Citrus limon Nutrition 0.000 description 13
- 244000131522 Citrus pyriformis Species 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 11
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 11
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 238000003860 storage Methods 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 230000014759 maintenance of location Effects 0.000 description 8
- 235000019483 Peanut oil Nutrition 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 239000000312 peanut oil Substances 0.000 description 7
- 235000019166 vitamin D Nutrition 0.000 description 7
- 239000011710 vitamin D Substances 0.000 description 7
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 6
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical group CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 6
- 241000040710 Chela Species 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 6
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000019832 sodium triphosphate Nutrition 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 4
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 4
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 4
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 4
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 4
- 239000008121 dextrose Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 4
- 229940038773 trisodium citrate Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 101710194948 Protein phosphatase PhpP Proteins 0.000 description 3
- -1 aliphatic ester Chemical class 0.000 description 3
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 229910001873 dinitrogen Inorganic materials 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 229950006191 gluconic acid Drugs 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 3
- 235000019173 retinyl acetate Nutrition 0.000 description 3
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 3
- 239000001433 sodium tartrate Substances 0.000 description 3
- 229960002167 sodium tartrate Drugs 0.000 description 3
- 235000011004 sodium tartrates Nutrition 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 229940095064 tartrate Drugs 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- UTGQNNCQYDRXCH-UHFFFAOYSA-N N,N'-diphenyl-1,4-phenylenediamine Chemical compound C=1C=C(NC=2C=CC=CC=2)C=CC=1NC1=CC=CC=C1 UTGQNNCQYDRXCH-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000005030 aluminium foil Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- STORWMDPIHOSMF-UHFFFAOYSA-N decanoic acid;octanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCC(O)=O.CCCCCCCCCC(O)=O STORWMDPIHOSMF-UHFFFAOYSA-N 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- WPEXVRDUEAJUGY-UHFFFAOYSA-B hexacalcium;(2,3,4,5,6-pentaphosphonatooxycyclohexyl) phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])(=O)OC1C(OP([O-])([O-])=O)C(OP([O-])([O-])=O)C(OP([O-])([O-])=O)C(OP([O-])([O-])=O)C1OP([O-])([O-])=O WPEXVRDUEAJUGY-UHFFFAOYSA-B 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000473 propyl gallate Substances 0.000 description 2
- 235000010388 propyl gallate Nutrition 0.000 description 2
- 229940075579 propyl gallate Drugs 0.000 description 2
- 229960000342 retinol acetate Drugs 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 239000011770 retinyl acetate Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 2
- 235000019801 trisodium phosphate Nutrition 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- XZYQCFABZDVOPN-ILXRZTDVSA-N Carotol Chemical compound C1C=C(C)CC[C@]2(O)[C@@H](C(C)C)CC[C@@]21C XZYQCFABZDVOPN-ILXRZTDVSA-N 0.000 description 1
- WKWATASPNZWAFM-UHFFFAOYSA-N Carotol Natural products CC1CCC2C(CCC(=C2C1)C)C(C)(C)O WKWATASPNZWAFM-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000019752 Wheat Middilings Nutrition 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 description 1
- HEAFLBOWLRRIHV-UHFFFAOYSA-N [Na].[P] Chemical compound [Na].[P] HEAFLBOWLRRIHV-UHFFFAOYSA-N 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- CUBCNYWQJHBXIY-UHFFFAOYSA-N benzoic acid;2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1O CUBCNYWQJHBXIY-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- UYIXLCLWCQXZBW-UHFFFAOYSA-J dicalcium;octadecanoate;phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UYIXLCLWCQXZBW-UHFFFAOYSA-J 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 238000006253 efflorescence Methods 0.000 description 1
- BEGBSFPALGFMJI-UHFFFAOYSA-N ethene;sodium Chemical group [Na].C=C BEGBSFPALGFMJI-UHFFFAOYSA-N 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- DZCAZXAJPZCSCU-UHFFFAOYSA-K sodium nitrilotriacetate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CC([O-])=O DZCAZXAJPZCSCU-UHFFFAOYSA-K 0.000 description 1
- 229940083982 sodium phytate Drugs 0.000 description 1
- PODWXQQNRWNDGD-UHFFFAOYSA-L sodium thiosulfate pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]S([S-])(=O)=O PODWXQQNRWNDGD-UHFFFAOYSA-L 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229910021654 trace metal Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 235000019263 trisodium citrate Nutrition 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Medicinal Preparation (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种氧化-敏感性化合物的稳定性混合物含有甘油酯、络合剂和覆盖物质及氧化-敏感性化合物。
Description
本发明涉及一种含有氧化-敏感性化合物的稳定混合物,并用于制备所述的混合物的方法,以及用于稳定氧化-敏感性化合物的物质的一种组合物。
当氧化-敏感性化合物,特别是脂溶性的维生素与空气接触时,会发生不希望的氧化。这就降低了含有这些敏感性化合物的产品的质量。特别是,当氧化-敏感性化合物用于食物、食品或药品时,该氧化-敏感性化合物在贮藏过程中由于氧化而受破坏,且在该产品中保留的这些化合物的比例下降。
为了抑制氧化,用一种抗氧化剂和(多价)螯合剂的组合物处理维生素、油和脂肪是可能的;参见E.富里埃(E.Furia),食物添加剂手册(Handbook of Food Additives),第2版,第271和274至281页(1975年),其中报道了(多价)螯合剂和抗氧化剂的复合作用是协同的。所述的(多价)螯合剂包括大量不同的化合物,例如醋酸盐、柠檬酸盐、乙二胺四乙酸盐、肌醇六磷酸钙和硫代硫酸钠等。该参考文献还提到甘油三酯,尽管不作为稳定剂,但正相反,可作为将被稳定的基体;参见上述参考文献,第280页。
(日本申请)JP-A-9204-696提出一种肌醇六磷酸、混旋α-维生素E(抗不育维生素)、天然维生素E或维生素C的组合物,用作为含有这些组分的油、脂肪酸和食物的抗氧化剂。
已提出各种方法用于稳定维生素A。例如,维生素A可被转化为乙酸酯或脂肪族酯,例如棕榈酯,且可加入一种合成的氧化抑制剂。这儿合适的氧化抑制剂为二丁基羟基甲苯(BHT)、丁基羟基苯甲醚(BHA)、去甲二氢愈创木酸(NDGA)、培酸丙酯(PG)或N,N′-二苯基对苯二胺(DPPD)。稳定维生素A的其它方法为用白明胶、酪蛋白、糊精或其它物质覆盖维生素A以切断与空气的接触,且然后制备珠粒(beadlet)或粉末。其它可能性是在天然苯酚类物质和抗坏血酸存在下将维生素A制成颗粒状或粉状固体;参见JP-A-122,424/84。
但是,对于稳定氧化-敏感性化合物的已有技术的建议是不合适的,因为既不能得到合适的该敏感性化合物的覆盖层,又不能防止由于痕量金属元素所引起的氧化促进作用。
本发明的一个目的在于提供一种氧化-敏感性化合物的稳定混合物,它是稳定的,并易于控制,且在食物、食品和药物应用中特别合适。
我们已发现通过提供一种含有氧化-敏感性化合物、一种甘油三酯、一种络合剂和一种覆盖物质的稳定混合物来达到该目的。
该甘油三酯、络合剂和覆盖物质的组合物能意想不到地给予该氧化-敏感性化合物完全保护。当这些三种活性物质的组合物的各组分仅具有较小保护效应时,该组合物给出一超加性保护效果。
在本发明的一个较好的具体实例中,该混合物附加地含有通常的抗氧化剂。它们可包括,例如,BHT、BHA和乙氧基奎。
在一个更好的具体实例中,该甘油三酯为植物油。该在本发明中有用的甘油三酯包括天然产品、从天然产品再生的甘油三酯和合成的甘油三酯。采用这些甘油三酯的一种或多种是可能的。参考文献给出应用植物油例如橄榄油、豆油、玉米油、棉子油、葵花油、花生油、棕榈油、椰子油和小麦胚芽油,也可以应用各种动物脂肪(例如
猪的脂肪、牛的脂肪、羊的脂肪和鱼油)和半合成脂肪,该半合成脂肪可通过酯基转移和再组合,包括分馏和氢化而得到。
在一个更好的具体实例中,该络合剂为肌醇六磷酸、磷酸、偏磷酸、焦磷酸或多磷酸或其一种盐。合适的盐特别是金属盐(钠盐、钾盐、钙盐)。
该络合剂还包括用于重金属离子的(多价)螯合剂和螯合剂。特别是就食物而论,应用在该文献[例如托马斯E.富里埃,食物添加剂手册,第2版,控制与报告中心出版社(CRC Press),第271-281页(1975年)]中所述的物质(食物)是可能的。例如,应用羧酸、多元羧酸、羟基羧酸、肌醇六磷酸、磷酸、多磷酸、氨基酸、酒石酸、葡糖酸、柠檬酸和乙二胺四乙酸和其金属盐(例如肌醇六磷酸钙、焦磷酸钠、六偏磷酸钠、三聚磷酸钠、酒石酸钠、葡糖酸钙、柠檬酸钠和乙二胺四乙酸钠)、柠檬酯、次氮基三乙酸钠(NTA-Na)、半胱氨酸、富马酸、马来酸和乳酸也是可能的。
应用络合剂的组合物也是可能的。
在本发明的更好的具体实例中,覆盖物质为一种成膜剂,特别是一种蛋白质如凝胶或酪蛋白,或一种糖或多糖,特别是***树胶、藻酸盐、淀粉或一种淀粉衍生物。一种合适的糖特别是蔗糖葡萄糖或乳糖。对抗氧化剂,例如BHT、BHA或乙氧基奎,流动性控制剂,例如二氧化硅、硬脂酸钙磷酸钙,还有填料,例如淀粉、高岭土和硅酸盐也是可能的。
根据本发明将包含在该混合物中的甘油三酯和络合剂与氧化-敏感性化合物的比例可随着在具体实施例中实际所用的化合物而变动。以1份重量的氧化-敏感性化合物为基准,例如用在1至0.01份重量范围内的甘油三酯和在1至0.01份重量范围内的络合剂是可能的。
因此与甘油三酯和络合剂混合的氧化-敏感性化合物可用所需
量的覆盖物质覆盖以得到该混合物的完全覆盖。
本发明的主题也是根据本发明制备该混合物的一种方法,它包括从一种氧化-敏感性化合物、一种甘油三酯、一种络合剂和一种覆盖物质制备成一种分散体,并将这种分散体转化为一固体物质。
通常,根据本发明的混合物通过制备一种分散在甘油三酯、络合剂、覆盖物质中的一种氧化-敏感性化合物的水质分散体,且若用辅助剂,用一般方法将这分散体转化为一种固体物质,且若需要随后再用干燥方法而得到。这样一种方法给出一种合适的稳定的氧化-敏感性化合物的混合物,包括该氧化-敏感性化合物、覆盖物质、甘油三酯和络合剂。
在根据本发明的方法中,水分散体或乳剂的制备一般是通过首先溶解该水溶性物质,例如覆盖物质,它是亲水组份,及在水中的其它辅助剂以得到水溶液,且同时预混合该脂溶性物质,例如该氧化-敏感性化合物和甘油三酯来制备。通过用合适的搅拌器或匀化器使预混合料和溶液进行混合,一切东西开始分散或乳化。所得到的分散体通过冷冻干燥、真空干燥、喷雾干燥或对流干燥转化为颗粒状或粉状固体物质或将该固体物质用合适的方法制成颗粒,然后再干燥该颗粒。
在根据本发明的方法中,该干燥方法之后可用附加(添加)处理以交联该覆盖物质。若白明胶用作为覆盖物质,例如,用醛交联或进行热交联处理是可能的。也有可能在干燥工艺之后应用另一覆盖物质,例如脂肪、链烷烃、蜡、合成聚合物,例如乙酸纤维素和邻苯二甲酸纤维素等。
特别好的是,该固体物质以粒状或粉状形式存在,在该情况下,平均微粒尺寸从100至600微米是特别好的。
在本发明中所述的该氧化-敏感性化合物包括脂溶性维生素、类胡萝卜素、维生素A酸和从中衍生的化合物类、类维生素A、香料
(例如柠檬油)和香剂等。应用这些化合物的一种或多种是可能的。脂溶性维生素包括例如维生素A、维生素E、维生素D、维生素K系列和这些维生素的混合物,它均不仅可以其游离的形式存在,而且可以酯的形式存在。类胡萝卜素包括例如β-胡萝卜素、班螯黄质(canthaxanthene)柠檬黄质(citranxanthene)、β-阿朴-8′-胡萝卜酸乙酯、虾青素(astaxanthene)、胡萝卜醇例如黄体素和玉米黄质,及这些类胡萝卜素的混合物。
但是,根据本发明的这些混合物还可含有其它非氧化-敏感性组份。
下面,本发明通过参照非限制性工作和应用实施例来解释。
工作实施例1
将220份白明胶、36份糖和96份糊精加至600份水中,并加热至70℃溶解。另外,加入220份已加有3.8份维生素D3和7.2份BHT的维生素A乙酸盐,通过融熔而均匀化。所得到的混合物通过搅拌而与44份豆油和72份乙氧基奎掺合而给出一种均相混合物。此后,将20份50%强度的肌醇六磷酸加至上述水溶液中,然后加入上述维生素溶液,通过分散和混合而得到维生素分散体。将该分散体导入喷粉塔并喷雾。然后在一个流化床干燥器上干燥而得到稳定的维生素A/D3粉末。
工作实施例2
将53份白明胶和113份葡萄糖糖浆加至100份水中,且在溶胀该白明胶30分钟之后,通过加热至70℃来溶解。此后接连加入不同量的一种甘油三酯和一种络合剂,然后加入50.1份已经加入4.5毫克BHT百万个国际单位(I.u.)和100毫克乙氧基奎/百万个国际单位而稳定的维生素A乙酸盐。再加入70份水,且该混合物通过剧烈搅拌而乳化。所得到的该乳剂最终在70℃下通过一可买得到的喷雾枪喷至装满疏水性二氧化硅的氮气氛中。接着将所得到的产品
在室温下、在流化床干燥器中、在氮气流中干燥。
用下列量的在配方中的甘油三酯和络合剂重复工作实施例2(所述的份的重量均以100份重量的干的粉末为基准,其中一种配方需要加入添加剂,因此相应减少葡萄糖糖浆的用量):
工作实施例2-1
不加入络合剂或甘油三酯。
工作实施例2-2
加入5%豆油,不加入络合剂。
工作实施例2-3
加入5%花生油,不加入络合剂。
工作实施例2-4
加入5%玉米油,不加入络合剂。
工作实施例2-5
加入1%肌醇六磷酸,不加入络合剂。
工作实施例2-6
加入1%肌醇六磷酸、5%豆油。
工作实施例2-7
加入1%肌醇六磷酸、5%豆油。
工作实施例2-8
加入1%肌醇六磷酸、2%豆油。
工作实施例2-9
加入1%肌醇六磷酸、10%豆油。
工作实施例2-10
加入1%肌醇六磷酸、5%花生油。
工作实施例2-11
加入1%肌醇六磷酸、5%玉米油。
工作实施例2-12
加入1%肌醇六磷酸的钠盐、5%豆油。
工作实施例2-13
加入1%肌醇六磷酸的钙盐、5%豆油。
工作实施例2-14
加入1%柠檬酸、5%豆油。
工作实施例2-15
加入1%柠檬酸钠、5%豆油。
工作实施例2-16
加入1%酒石酸、5%豆油。
工作实施例2-17
加入1%酒石酸钠、5%豆油。
工作实施例2-18
加入1%水扬酸、5%豆油。
工作实施例2-19
加入1%葡糖酸、5%豆油。
工作实施例2-20
加入1%磷酸、5%豆油。
工作实施例2-21
加入1%焦磷钠、5%豆油。
工作实施例2-22
加入1%六偏磷酸钠、5%豆油。
工作实施例2-23
加入1%三聚磷酸钠、5%豆油。
工作实施例2-24
工作实施例2-25
加入1%NTA-Na(Titriplex Ⅰ)、5%豆油。
工作实施例2-26
加入1%半胱氨酸、5%豆油。
工作实施例2-27
加入0.5%肌醇六磷酸、5%豆油。
工作实施例2-28
工作实施例2-29
加入1%柠檬酸钠,不加入甘油三酯。
工作实施例2-30
加入1%磷酸,不加入甘油三酯。
工作实施例2-31
加入1%六偏磷酸钠、5%花生油。
工作实施例2-32
加入1%六偏磷酸钠,不加入甘油三酯。
工作实施例2-33
加入1%Triplex Ⅲ,不加入甘油三酯。
工作实施例2-34
加入1%半胱氨酸,不加入甘油三酯。
工作实施例3
在室温下,加入126.8份葡萄糖糖浆之后,使52.3份重量的白明胶在150份水中溶胀,此后加热该混合物至65℃。在加入50份抗不育维生素之后在该温度下,通过剧烈搅拌使该混合物乳化20分钟。然后,该乳剂通过一种物料的喷嘴(one-material nozzle)喷至装满疏水性二氧化硅的氮气氛中。所形成的该产品颗粒在氮气流中、在玻璃吸滤器上干燥,直至剩余的水分含量为3%。
用下列量的在配方中的一种脂肪酸甘油三酯和一种络合剂重复
工作实施例3,所述的份的重量均以100份重量的所得到的干的粉末为基准。
工作实施例3-1
不加入络合剂或脂肪酸甘油三酯或植物油。
工作实施例3-2
不加入络合剂,加入5%豆油。
工作实施例3-3
加入1%六偏磷酸钠,不加入植物油。
工作实施例3-4
加入1%六偏磷酸钠、5%豆油。
工作实施例4
根据工作实施例3的方针,使52.3份白明胶在122份在180份水中的葡萄糖糖浆中溶胀,并加热至60℃,加入52.4份维生素A乙酸盐(2.1百万个国际单位/克),用100毫克乙氧基奎/百万个国际单位和0.55份维生素D3(40百万个国际单位/克)稳,且乳化混合物20分钟。所得乳浊液照前述进行喷雾,然后,所得到的该产品在氮气流中干燥。
用另外所述的物质、下列量的一种配方中的和脂肪酸甘油三酯和一种络合剂重复工作实施例4,所述的份的重量均以100份重量的所得到的干的粉末为基准。
工作实施例4-1
不加入络合剂或植物油。
工作实施例4-2
加入1%肌醇六磷酸和5%豆油。
工作实施例5
工作实施例5-1
在6.0至6.5巴下,在喷雾塔中,用一种物料的喷嘴,在50℃
下,将一种由4.9%柠檬黄质(微粉化的)、0.3%维生素C棕榈酸酯、1.6%乙氧基奎、14.6%白明胶100黄色粉末、13.1%蔗糖、65.5%水构成的柠檬黄质分散体喷至疏水性二氧化硅的浮云状物中。该潮湿的产物在室温下、在流化床干燥器上干燥至剩余水分含量约4%。该粉末的活性物质含量为13.7%。
工作实施例5-2
如工作实施例5-1处理一种由4.3%柠檬黄质(微粉化的)、0.3%维生素C棕榈酸酯、1.4%乙氧基奎、12.7%白明胶100黄色粉末、9.7%蔗糖、1.6%豆油、70%水构成的柠檬黄质分散剂。该粉末的活性物质含量为13.2%。
工作实施例5-3
如工作实施例5-1处理一种由4.5%柠檬黄质(微粉化的)、0.3%维生素C棕榈酸酯、1.5%乙氧基奎、13.2%白明胶100黄色粉末、9.7%蔗糖、1.7%豆油、0.4%肌醇六磷酸(作为Na盐)、68.7%水构成的柠檬黄质分散体。该粉末的活性物质含量为13.2%。
工作实施例5-4
如工作实施例5-1处理一种由4.8%柠檬黄质分散剂(微粉化的)、0.3%维生素C棕榈酸酯、1.5%乙氧基奎、13.5%白明胶100黄色粉末、9.7%蔗糖、1.8%豆油、0.4%乙二胺四乙酸(作为Na盐)构成的柠檬黄质分散体。该粉末的活性物质含量为13.0%。
工作实施例6
工作实施例6-1
在40℃下,通过剧烈搅拌,将200份一种由106.8份水、1.1份防腐剂混合物、3.8份乙氧基奎、47.3份蔗糖、29份白明胶(B型200)和13.3份微粉化的班螯黄质构成的分散体分散至400份石蜡油中。冷却至18℃之后,所形成的该颗粒的表面通过外加玉米淀粉而粉化。该产品,它现在以直径从50至500微米的微球的形式存
在,用2000份冷的石油醚洗涤,并最后在室温下、在流化床干燥器上干燥至剩余水分含量为4%。该粉末的活性物质含量为10.7%。
工作实施例6-2
重复工作实施例6-1,除了将附加的4.0份豆油和0.8份肌醇六磷酸加至该乳剂中,提供了,在用与工作实施例6-1相似的方法完成之后,一种具有班螯黄质含量10.1%、一种肌醇六磷酸含量1%和豆油含量5%的粉末。
应用实施例1
含有维生素A/D3的干的粉末的测试
不进行预混合而将1.0克工作实施例1的该粉末导入玻璃瓶中,在恒温40℃及70%相对湿度下贮藏该玻璃瓶,并每隔一段时间测量一下该剩余的维生素A的比例。该结果在下列表中显示出。
10克工作实施例1的该粉末与40克包括50%麦麸、30%的50%强度的胆碱盐酸盐和10%痕量元素混合物的预混合基质混合。将因此所得到的3.2%预混合物导入玻璃瓶中,它然后用铝箔代替盖子覆盖,并在该铝箔中制5个洞以通风(或换气)。在恒温40℃和恒定的相对湿度70%下,将该瓶放在一容器中,且在某一时间测量一下该剩余的维生素A的比例(保留值%)。上述痕量元素包括一种37.44%CuSO4×5H2O、46.78%FeSO4×7H2O、11.78%ZnO、3.61%MnO和0.39%CoCO3的混合物。
该测试结果在下列表Ⅰ中显示出:
表Ⅰ
维生素A保留值(%)
测试 天数 1个月后(%) 2个月后(%)
工作实施例1的粉末 100 90 86
与工作实施例1的该 100 63 52
粉末混合物的预混合物
与工作实施例1相似 100 59 40
但无豆油和肌醇六偏磷
酸的粉末
应用实施例2
含有维生素A的干的粉末的测试
将1%重量的工作实施例2的各粉末与99%在应用实施例1中所述的预混合物混合。4克这些混合物的样品,在40℃和70%相对湿度的调节箱中,在贮藏开始和贮藏了4个星期之后测试其维生素A含量。在4个星期之后的该剩余的比例在下列表Ⅱ和Ⅲ中以贮藏的起始值的%报道:
表Ⅱ
维生素A(涉及应用实施例2)
工作实施 络合剂 油 4个星期之后
例编号 的保留值(%)
2-1 - - 17
2-2 - 5%豆油 32
2-3 - 5%花生油 31
2-4 - 5%棉子油 46
2-5 1%肌醇六磷酸 - 24
2-6 1%肌醇六磷酸 5%豆油 47
2-7 1.5%肌醇六磷 5%豆油 53
酸
2-8 1%肌醇六磷酸 2%豆油 55
2-9 1%肌醇六磷酸 10%豆油 59
2-10 1%肌醇六磷酸 5%花生油 53
2-11 1%肌醇六磷酸 5%玉米油 54
2-12 1%肌醇六磷酸 5%豆油 58
钠
2-13 1%肌醇六磷酸 5%豆油 59
钙
2-14 1%柠檬酸 5%豆油 46
2-15 1%柠檬酸钠 5%豆油 53
2-16 1%酒石酸 5%豆油 49
2-17 1%酒石酸钠 5%豆油 55
2-18 1%水杨酸 5%豆油 53
2-19 1%葡糖酸 5%豆油 50
2-20 1%磷酸 5%豆油 63
2-21 1%焦磷酸钠 5%豆油 57
2-22 1%六偏磷酸钠 5%豆油 53
2-23 1%三聚磷酸钠 5%豆油 57
2-24 1%EDTA钠
(TitriplxⅢ) 5%豆油 59
2-25 1%NTA钠
(TitriplexⅠ) 5%豆油 51
2-26 1%半胱氨酸 5%豆油 59
2-27 1%肌醇六磷酸 5%豆油 29
表Ⅲ
维生素A(涉及应用实施例2)
工作实施 络合剂 油 十个星期之后
例编号 的保留值(%)
2-28 1%肌醇六磷酸 5%合成甘油三酯*) 54
钠
2-29 1%柠檬酸钠 - 13
2-30 1%磷酸 - 55
2-31 1%六偏磷酸钠 5%花生油 44
2-32 1%六偏磷酸钠 - 28
2-33 1%EDTA钠 - 20
(TitriplexⅢ)
2-34 1%半胱氨酸 - 25
*)Myglyol812(中性油)=辛己酸甘油三酯
应用实施例3
含有抗不育维生素的干的粉末测试
将1%重量的工作实施例3的各粉末与99%在应用实施例1中所述的预混合物混合。将6克这些混合物的样品,放在40℃和70%相对湿度的调节箱中,在贮藏开始和贮藏了4个星期之后测试其抗不育维生素含量。在4个星期之后的该保留的比例在下列表中以贮藏的起始值的百分比报道:
工作实施 络合剂 油 4个星期之后的
例编号 保留值(%)
3-1 - - 18
3-2 - 5%豆油 23
3-3 1%六偏磷酸钠 - 41
3-4 1%六偏磷酸钠 5%豆油 49
应用实施例4
含有维生素D3的干的粉末的测试
在与应用实施例5中相同的预混合中测试工作实施例4的维生素A/D3的干的粉末。在每千克预混合物中混合2百万个国际单位的维生素D3。将10克该准备制备的混合物的样品放在40℃和70%
相对湿度的调节箱中,在贮藏开始和贮藏了4和8个星期之后测试其维生素D3含量。在8个星期之后的该保留的比例在下列表中以贮藏的起始值的百分比报道:
工作实施 络合剂 油 4个星期之后的
例编号 保留值(%)
4-1 - - 40
4-2 1%肌醇六磷酸 5%豆油 81
应用实施例5
含有类胡萝卜素的干的粉末的测试
工作实施例5和6的含有类胡萝卜素的干的粉末,在下列配方的预混合物中测试其稳定性:76%粗小麦粉、13.3%胆碱盐酸盐液体(含有75%胆碱盐酸盐和25%水)和10%应用实施例1的该痕量元素。在混入1%重量的该类胡萝卜素的干的粉末之前,贮藏该预混合物3天。1克该已制备的混合物的样品,在40℃和70%相对湿度的调节箱中,在贮藏开始和贮藏了4个星期之后测试其类胡萝卜素含量。在4个星期之后的该剩余的比例在下列表中以贮藏的起始值的百分比报道:
工作实施 络合剂 油 4个星期之后的例
编号 保留值(%)
5-1 柠檬黄质 - 22
5-2 柠檬黄质 5%豆油 48
5-3 柠檬黄质 5%豆油 68
工作实施 活性物质 络合剂 油 4个星期之后
例编号 的保留值(%)
5-4 班螯黄质 1%EDTA钠 5%豆油 63
6-1 班螯黄质 - - 33
6-2 班螯黄质 1%肌醇六磷酸 5%豆油 79
Claims (10)
1、一种含有1份(重量)氧化-敏感性化合物、1-0.01份(重量)甘油三酯、1-0.01份(重量)选自重金属离子和螯合剂的络合剂和一种覆盖物质的稳定性混合物。
2、根据权利要求1所述的一种混合物,其特征在于其中所述的甘油三酯为植物油。
3、根据权利要求1所述的一种混合物,其特征在于其中所述的络合剂为肌醇六磷酸、磷酸、偏磷酸、焦磷酸或多磷酸或其一种盐。
4、根据权利要求1所述的一种混合物,其特征在于其中所述的覆盖物质为成膜剂。
5、根据权利要求1所述的一种混合物,其特征在于其中所述的氧化-敏感性化合物为脂溶性维生素或类胡萝卜素。
6、根据权利要求1所述的一种混合物,其特征在于氧化-敏感性化合物为维生素A或其一种酯、络合剂为肌醇六磷酸、甘油三酯为植物油和覆盖物质为白明胶。
7、根据权利要求1所述的一种混合物,其特征在于其以颗粒状形式存在,具有从100至600微米的颗粒尺寸。
8、一种制备含氧化-敏感性化合物的稳定性混合物的方法,包括将1份(重量)氧化-敏感性化合物与1-0.01份(重量)甘油三酯和1-0.01(重量)络合剂混合,然后用覆盖物质覆盖此混合物。
9、根据权利要求8所述的一种方法,其特征在于其中混合和覆盖步骤是在含水状态下进行的。
10、一种含1份(重量)的氧化-敏感性化合物,1-0.01份(重量)甘油三酯,1-0.01份(重量)选自重金属离子和螯合剂的络合剂,和覆盖物质的稳定性混合物的应用,其特征在于用以稳定一种氧化-敏感性化合物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1723288 | 1988-01-29 | ||
JP017232/88 | 1988-01-29 | ||
JP9786/89 | 1989-01-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1036220A CN1036220A (zh) | 1989-10-11 |
CN1023229C true CN1023229C (zh) | 1993-12-22 |
Family
ID=11938201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN89100550A Expired - Fee Related CN1023229C (zh) | 1988-01-29 | 1989-01-27 | 含有氧化-敏感性化合物的稳定性混合物,其制备及其组合物的应用 |
Country Status (10)
Country | Link |
---|---|
US (1) | US4929774A (zh) |
EP (1) | EP0326026B1 (zh) |
KR (1) | KR890011974A (zh) |
CN (1) | CN1023229C (zh) |
CA (1) | CA1331136C (zh) |
DE (1) | DE58901641D1 (zh) |
DK (1) | DK174663B1 (zh) |
IL (1) | IL88961A (zh) |
IN (1) | IN171845B (zh) |
SU (1) | SU1639425A3 (zh) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2610626B1 (fr) * | 1987-02-09 | 1989-05-19 | Oreal | Nouveau systeme anti-oxydant a base d'un ester d'ascorbyle stabilise, contenant en association au moins un agent complexant et au moins un thiol, et compositions contenant un tel systeme anti-oxydant |
JPH02124894A (ja) * | 1988-11-01 | 1990-05-14 | Sanwa Kagaku Kenkyusho Co Ltd | フィチン酸安定化組成物 |
US5180747A (en) * | 1989-02-28 | 1993-01-19 | Nisshin Flour Milling Co., Ltd. | Stabilized fat-soluble vitamin compositions |
US5290605A (en) * | 1989-06-29 | 1994-03-01 | Niva Shapira | Sun-exposure nutritional supporting composition |
KR930006431B1 (ko) * | 1990-10-11 | 1993-07-16 | 재단법인 한국화학연구소 | 약물의 미세캡슐화 방법 |
ES2289370T3 (es) * | 1992-07-13 | 2008-02-01 | Shiseido Company, Ltd. | Composicion estabilizada para tratamiento cutaneo externo que comprende retinol. |
US5270063A (en) * | 1992-08-03 | 1993-12-14 | Kellogg Company | Ready-to-eat cereal products enriched with beta-carotene |
FR2703263B1 (fr) * | 1993-03-31 | 1995-05-19 | Rhone Poulenc Nutrition Animal | Procédé de préparation de sphérules de principes actifs. |
IL110139A0 (en) * | 1993-06-28 | 1994-10-07 | Howard Foundation | Pharmaceutically-active antioxidants |
JPH07203950A (ja) * | 1994-01-26 | 1995-08-08 | Kanegafuchi Chem Ind Co Ltd | 被覆されたファフィア・ロドチーマ酵母及びその造粒物 |
AUPM677594A0 (en) * | 1994-07-12 | 1994-08-04 | Daratech Pty Ltd | Preservation of exposed underground plant structures |
US5817351A (en) * | 1995-04-07 | 1998-10-06 | Abbott Laboratories | Calcium fortified low pH beverage |
JPH11503023A (ja) * | 1995-04-07 | 1999-03-23 | アボット・ラボラトリーズ | ビタミンdを含有するカルシウム補給剤およびカルシウム含有飲料 |
DE19518845A1 (de) * | 1995-05-23 | 1996-11-28 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Phytinsäure |
US5827904A (en) * | 1996-09-27 | 1998-10-27 | Hahn; David | Medical implant composition |
AU752468B2 (en) | 1997-04-04 | 2002-09-19 | Phyllis E. Bowen | Lutein esters having high bioavailability |
US6007856A (en) * | 1997-08-08 | 1999-12-28 | The Procter & Gamble Company | Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid |
US20020068090A1 (en) * | 1999-02-03 | 2002-06-06 | Bell Steve J. D. | Calcium phosphate particles as mucosal adjuvants |
US20040258763A1 (en) * | 1999-02-03 | 2004-12-23 | Bell Steve J.D. | Methods of manufacture and use of calcium phosphate particles containing allergens |
CA2361421A1 (en) | 1999-02-03 | 2000-08-10 | Biosante Pharmaceuticals, Inc. | Therapeutic calcium phosphate particles and methods of manufacture and use |
US20020054914A1 (en) * | 1999-02-03 | 2002-05-09 | Tulin Morcol | Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein |
US6328995B1 (en) * | 1999-09-24 | 2001-12-11 | Basf Aktiengesellschaft | Stable vitamin and/or carotenoid products in powder form and process for their production |
EP1355877A1 (en) * | 2001-01-30 | 2003-10-29 | Sabinsa Corporation | Process of obtaining compositions of stable lutein and lutein derivatives |
US20060062855A1 (en) * | 2001-02-27 | 2006-03-23 | Bell Steve J D | Therapeutic calcium phosphate particles for use in inhibiting expression of a gene |
US20030185892A1 (en) * | 2001-08-17 | 2003-10-02 | Bell Steve J. D. | Intraocular delivery compositions and methods |
DE10300325A1 (de) | 2003-01-09 | 2004-07-22 | Hexal Ag | Granulat mit öliger Substanz, Herstellungsverfahren und Tablette |
US20060110517A1 (en) | 2003-01-31 | 2006-05-25 | Reinhold Carle | Novel compositions comprising carotenoids |
DE10311585A1 (de) | 2003-03-14 | 2004-09-23 | Basf Ag | Wirkstoffhaltige Adsorbate |
DE10325989A1 (de) * | 2003-06-07 | 2005-01-05 | Glatt Gmbh | Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung |
US7446101B1 (en) * | 2003-12-12 | 2008-11-04 | Bioactives, Llc | Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems |
US9247765B2 (en) | 2004-01-14 | 2016-02-02 | Omniactive Health Technologies Limited | Stable beadlets of lipophilic nutrients |
PT1729797E (pt) | 2004-03-22 | 2008-12-17 | Solvay Pharm Gmbh | Composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina, contendo tensioactivos |
US7351424B2 (en) * | 2004-07-22 | 2008-04-01 | Bio Lut S.A. De C.V. | Enhanced purity trans-lutein-ester compositions and methods of making same |
CA2575396C (en) * | 2004-07-30 | 2012-11-13 | Wakunaga Pharmaceutical Co., Ltd. | Composition for capsule coating, capsule coating, and capsule using the same |
EP1811941A4 (en) * | 2004-11-01 | 2008-09-10 | Biosante Pharmaceuticals Inc | CALCIUM PHOSPHATE THERAPEUTIC PARTICLES FOR AESTHETIC OR COSMETIC MEDICINE, AND METHODS OF MAKING AND USING THE SAME |
AU2006274835B2 (en) | 2005-07-29 | 2012-05-24 | Abbott Laboratories Gmbh | Processes for the manufacture of sterilized pancreatin powder |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US20070065487A1 (en) * | 2005-09-21 | 2007-03-22 | Bio Lut S.A. De C.V. | Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
US20090130063A1 (en) * | 2007-11-15 | 2009-05-21 | Solvay Pharmaceuticals Gmbh | Process for separating and determining the viral load in a pancreatin sample |
ES2969807T3 (es) * | 2016-03-24 | 2024-05-22 | Basf Se | Preparados de principios activos de múltiples fases |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5614338B2 (zh) * | 1973-05-31 | 1981-04-03 | ||
DE3135329A1 (de) * | 1981-09-05 | 1983-03-24 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen |
JPS59122424A (ja) * | 1982-12-29 | 1984-07-14 | Riken Vitamin Co Ltd | ビタミンa組成物およびその製造法 |
JPS59204696A (ja) * | 1983-05-06 | 1984-11-20 | 三井製薬工業株式会社 | 酸化防止剤 |
JPS62111676A (ja) * | 1985-11-12 | 1987-05-22 | Nippon Oil & Fats Co Ltd | 酸化防止製剤 |
-
1989
- 1989-01-16 IL IL88961A patent/IL88961A/xx not_active IP Right Cessation
- 1989-01-18 IN IN42/MAS/89A patent/IN171845B/en unknown
- 1989-01-20 DE DE8989100908T patent/DE58901641D1/de not_active Expired - Lifetime
- 1989-01-20 EP EP89100908A patent/EP0326026B1/de not_active Expired - Lifetime
- 1989-01-27 CN CN89100550A patent/CN1023229C/zh not_active Expired - Fee Related
- 1989-01-27 CA CA000589338A patent/CA1331136C/en not_active Expired - Fee Related
- 1989-01-27 SU SU894613322A patent/SU1639425A3/ru active
- 1989-01-27 US US07/302,611 patent/US4929774A/en not_active Expired - Lifetime
- 1989-01-27 DK DK198900355A patent/DK174663B1/da not_active IP Right Cessation
- 1989-01-28 KR KR1019890000932A patent/KR890011974A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0326026B1 (de) | 1992-06-17 |
DE58901641D1 (de) | 1992-07-23 |
DK35589D0 (da) | 1989-01-27 |
SU1639425A3 (ru) | 1991-03-30 |
CN1036220A (zh) | 1989-10-11 |
IL88961A0 (en) | 1989-08-15 |
KR890011974A (ko) | 1989-08-23 |
DK174663B1 (da) | 2003-08-18 |
IN171845B (zh) | 1993-01-23 |
US4929774A (en) | 1990-05-29 |
CA1331136C (en) | 1994-08-02 |
DK35589A (da) | 1989-07-30 |
EP0326026A3 (en) | 1990-11-14 |
EP0326026A2 (de) | 1989-08-02 |
IL88961A (en) | 1992-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1023229C (zh) | 含有氧化-敏感性化合物的稳定性混合物,其制备及其组合物的应用 | |
CN1278690C (zh) | 25-羟基维生素d3组合物 | |
CN1250101C (zh) | 涂覆聚合物的、粒状含酶饲料添加剂及其制备方法 | |
CN1065263C (zh) | 干薄膜涂料组合物及其制备方法和用途 | |
CN1747658A (zh) | 含有活性化合物的吸附物 | |
CN1170517C (zh) | 含水粉末组合物及其制造方法和含该粉末组合物的化妆料 | |
CN1029107C (zh) | 用于农业化学品或同类物的容器包装*** | |
CN1620413A (zh) | 还原型辅酶q10的稳定方法和组合物 | |
CN1091614C (zh) | 苦味消除剂 | |
EP3582627B1 (en) | Storage-stable formulations | |
CN1976591A (zh) | 包装的焙烤用粉末组合物 | |
CN1092643A (zh) | 增湿性唇膏组合物 | |
CN1847368A (zh) | 增加生物柴油的氧化稳定性的方法 | |
CN101060792A (zh) | 用于活性成分制剂的经改良植物胶 | |
CN1917850A (zh) | 液态乳化化妆品 | |
CN1390095A (zh) | 含水和油的乳液 | |
CN101068477A (zh) | 食品 | |
CN1181068A (zh) | 固体二酰基有机过氧化物分散体 | |
CN1068959A (zh) | 胶囊化的生物活性物质 | |
CN1149968C (zh) | 水包油型乳化组合物 | |
CN1700912A (zh) | 抗坏血酸胆碱配制剂 | |
CN1703195A (zh) | 油性固态化妆品及其制造方法 | |
CN1027028C (zh) | 杀虫透明乳液 | |
CN1833541A (zh) | 一种辣椒食品及其制作方法 | |
CN1174505A (zh) | 含有那蒙特金的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C53 | Correction of patent of invention or patent application | ||
COR | Change of bibliographic data |
Free format text: CORRECT: PATENTEE; FROM: BASF AG TO: NISSIN BASF CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Patentee after: The BASF Corporation Patentee before: Basf AG |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |